CK14 expression may regulate the treatment response to cancer therapeutics, including chemotherapy, immunotherapy, and Bacillus Calmette-Guérin in urothelial carcinoma (1, 7–10, 19, 21, 52). The gene discussed is KRT14; the disease is urothelial carcinoma.